Chemical mediators in atopic dermatitis: Involvement of leukotriene B4 released by a type I allergic reaction in the pathogenesis of atopic dermatitis

Journal of Allergy and Clinical Immunology

Volumn 103, Issue 4, 1999, Pages 663-670

  Koro, Osamu ^a   Furutani, Kiyoshi ^a   Hide, Michihiro ^a   Yamada, Satoru ^a   Yamamoto, Shoso ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Atopic dermatitis; Histamine; Late phase response; Leukotriene B4; Neutrophil chemotactic activity; Type I allergy

Indexed keywords

ANTIGEN; HISTAMINE; LEUKOTRIENE B4;

ADOLESCENT; ADULT; ANTIGEN SPECIFICITY; ARTICLE; ATOPIC DERMATITIS; CELLULAR IMMUNITY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMEDIATE TYPE HYPERSENSITIVITY; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MEDIATOR RELEASE; NEUTROPHIL CHEMOTAXIS; PATHOGENESIS; PRIORITY JOURNAL; PROVOCATION TEST; SENSITIZATION;

EID: 0033056333     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(99)70240-X     Document Type: Article

References (42)

1. 1. Jones HE, Inouye JC, McGerity JL, Lewis CW. Atopic disease and serum immunoglobulin-E. Br J Dermatol 1975;92:17-25.
2. 2. Ogawa M, Berger PA, McIntyre OR, Clendenning WE, Ishizaka K. IgE in atopic dermatitis. Arch Dermatol 1971;103:575-80.
3. 3. Champion MD, Rowntree S, Mitchell EB, DiPrisco de Fuenmajor MC, Platts-Mills TAE. Quantitative assessments or IgG and IgE antibodies to inhalant allergens in patients with atopic dermatitis. J Allergy Clin Immunol 1983;72:27-33.
4. 4. Carswell F, Thompson S. Does natural sensitzation in eczema occur through the skin? Lancet 1986;2:13-5.
5. 5. Mihm MC, Soter NA, Dvorak HF, Frank Austen K. The structure of normal skin and the morphology of atopic eczema. J Invest Dermatol 1976;67:305-12.
6. 6. Greaves MW, Yamamoto S, Fairley VM. IgF mediated hypersensitivity in human skin studied using a new in vitro method. Immunology 1972;23:239-48.
7. 2 from human skin in vivo and in vitro during immediate allergic reactions. Br J Pharmacol 1988;94:773-80.
8. 8. Reshef A, Kagey-Sobotka A, Franklin Adkinson N Jr, Lichtenstein LM, Norman PS. The pattern and kinetics in human skin of erythema and mediators during the acute and late-phase response (LPR). J Allergy Clin Immunol 1989;84:678-87.
9. 9. Gleich GJ. The late phase of the immunoglobulin E-mediated reaction: A link between anaphylaxis and common allergic disease? J Allergy Clin Immunol 1982;70:160-9.
10. 10. Udén A-M, Palmblad J, Lindgren J-Å, Malmsten C. Effects of novel lipoxygenase products on migration of eosinophils and neutrophils in vitro. Int Arch Allergy Appl Immunol 1983;72:91-3.
11. 4) in human skin. J Invest Dermatol 1983;80:115-9.
12. 12. Rajka G, Langeland T. Grading of the severity of atopic dermatitis. Acta Derm Venereol (Stockh) Suppl 1989;144:13-4.
13. 13. Norman PS. In vivo methods of study of allergy. Skin and mucosal tests, techniques, and interpretation. In: Middleton E, Reed CE, Ellis E, editors. Allergy: principles and practice. 2nd ed. Vol II. St. Louis: Mosby; 1983. p. 295-302.
14. 14. Brain S, Camp RDR, Dowd P, Kobza Black A, Greaves MW. The release of leukotriene B4-like material in biologically active amounts from the lesional skin of patients with psoriasis. J Invest Dermatol 1984;83:70-3.
15. 15. Boyden S. The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leukocytes. J Exp Med 1962;115:453-66.
16. 16. Tsuruta Y, Kohashi K, Ohkura Y. Simultaneous determination of histamine and N-methyl-histamine in human urine and rat brain by high-performance liquid chromatography with fluorescence detection. J Chromatogr 1981;224:105-10.
17. 4 as the neutrophil chemotactic factor released by antigen challenge from passively sensitized guinea pig lungs. J Allergy Clin Immunol 1989;83:136-43.
18. 4 as a mediator of early and late reactions to antigen in humans. The effect of systemic glucocorticoid treatment in vivo. J Allergy Clin Immunol 1989;83:634-42.
19. 4 by human lung fragments and purified human lung mast cells. Am Rev Respir Dis 1988;138:389-94.
20. 20. Robinson C, Benyon C, Holgate ST, Church MK. IgE-and calcium-dependent release of eicosanoids and histamine from human purified cutaneous mast cells. J Invest Dermatol 1989;93:397-404.
21. 4. Eur J Biochem 1991;196:395-400.
22. 22. Fonteh AN, Bass DA, Marshall LA, Seeds M, Samet JM, Chilton FH. Evidence that secretory phospholipase A2 plays a role in arachidonic acid release and eicosanoid biosynthesis by mast cells. J Immunol 1994;152:5438-46.
23. 23. Wershil BK, Wang ZS, Gordon JR, Galli SJ. Recruitment of neutrophils during IgE-dependent cutaneous late phase reactions in the mouse is mast cell-dependent. Partial inhibition of the reaction with antiserum against tumor necrosis factor-alpha. J Clin Invest 1991;87:446-53.
24. 24. Obayashi T, Tamura H, Tanaka S, Ohki M, Takahashi S, Arai M. A new chromogenic endotoxin-specific assay using recombined limulus coagulation enzymes and its clinical applications. Clin Chim Acta 1985;149:55-66.
25. 25. Glauser FL, Palmer J, Cecconi S, Schoolcraft W, Wells I, Novey H, et al. The effect of endotoxin on the mast cell cAMP system. Ann Allergy 1977;38:104-6.
26. 26. Aderem A, Cohen DS, Wright SD, Cohn ZA. Bacterial lipopolysaccharides prime macrophages for enhanced release of arachidonic acid metabolites. J Exp Med 1986;164:165-79.
27. 27. Gleich GJ. The late phase of the immunoglobulin E mediated reaction: A link between anaphylaxis and common allergic disease? J Allergy Clin Immunol 1982;70:160-9.
28. 28. Dolovich J, Hargreave FE, Chalmers R, Shier KJ, Gauldie J, Bienenstock J. Late cutaneous allergic responses in isolated IgE-dependent reactions. J Allergy Clin Immunol 1973;52:38-46.
29. 29. Mitchell EB, Crow J, Chapman MD, Jouhal SS, Pope FM, Platts-Mills TAE. Basophils in allergen-induced patch test sites in atopic dermatitis. Lancet 1982;1:127-30.
30. 30. Ring J, Dorsch W. Altered releasability of vasoactive mediator secreting cells in atopic dermatitis. Acta Derm Venereol (Stockh) 1985;114:9-23.
31. 31. Bernhisel-Broadbent J, Pampson HA. Role of food allergy in atopic eczema. In: Ruzicka T, Ring J, Przybilla B, editors. Handbook of atopic eczema. Berlin: Springer-Verlag; 1991. p. 204-11.
32. 32. Charlesworth EN, Hood AF, Soter NA, Kagey-Sobotka A, Norman PS, Liechtenstein LM. Cutaneous late-phase response to allergen. Mediator release and inflammatory cell infiltration. J Clin Invest 1989;83:1519-26.
33. 33. Ruzicka T, Simmet T, Peskar BA, Ring J. Skin levels of arachidonic acid-derived inflammatory mediators and histamine in atopic dermatitis and psoriasis. J Invest Dermatol 1986;86:105-8.
34. 4 are present in biologically active concentrations. J Allergy Clin Immunol 1989;83:450-5.
35. 4 in human skin after repeated antigen challenge. J Allergy Clin Immunol 1989;83:691-6.
36. 36. Werfel S, Massey W, Lichtenstein LM, Bochner BS. Preferential recruitment of activated, memory T lymphocytes into skin chamber fluids during human cutaneous late-phase allergic reactions. J Allergy Clin Immunol 1995;96:57-65.
37. 37. Sawada K, Nagai H, Basaki Y, Yamaya H, Ishizawa K, Watanabe M, et al. The expression of murine cutaneous late phase reaction requires both antibodies and CD4 T cells. Clin Exp Allergy 1996;27:225-31.
38. 38. Bochner BS, Charlesworth EN, Lichtensiein EM, Derse CP, Gillis S, Dinurello CA, et al. Interleukin-1 is released at sites of human cutaneous allergic reaction. J Allergy Clin Immunol 1990;86:830-9.
39. 39. Lee CE, Neuland ME, Teaford HG, Villacis BE, Dixon PS, Valtier S, et al. Interleukin-6 is released in the cutaneous response to allergen challenge in atopic individuals. J Allergy Clin Immunol 1992;89:1010-20.
40. 40. Massey W, Friedman B, Kat M, Cooper P, Kagey-Sobotka A, Lichtenstein LM, et al. Appearance of granulocyte-macrophage colony-stimulating factor activity at allergen-challenged cutaneous late-phase reaction sites. J Immunol 1993;150:1084-92.
41. 41. Zweiman B, Kaplan AP, Tong L, Moskovitz AR. Cytokine levels and inflammatory responses in developing late-phase allergic reactions in the skin. J Allergy Clin Immunol 1997;100:104-9.
42. 42. Alam R, Kumar D, Anderson-Wallers D, Forsythe PA. Macrophage inflammatory protein-1α and monocyte chemoattractant peptide-1 elicit immediate and late cutaneous reactions and activate murine mast cells in vivo. J Immunol 1994;152:1298-303.